Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHIANTI trial of colchicine in moderate aortic stenosis
NL-OMON59834Phase 3Recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Dec 2024
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in aortic stenosis (AS) and aortic valve calcification (CAVD) comparing Colchicine with Placebo (2 arms). Primary endpoint: Change in aortic valve calcium score. Started Dec 2024; status: recruiting.
02
Drugs
colchicine
03
Conditions
aortic stenosis (AS)aortic valve calcification (CAVD)
Beyond the preview
Go deeper on NL-OMON59834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59834.